Compound synthesis and characterization.
(1) N-Terminus fragments (4S)-2-Oxooxazolidine-4-carboxylic acid (3a). To a solution of N-benzyloxycarbonyl-L-serine (18.9 g, 79.0 mmol) in methanol (160 mL), 1 M aqueous sodium hydroxide solution (160 mL, 160 mmol) was added and the mixture was stirred for 4 h at room temperature. The mixture was concentrated under reduced pressure. To the residue, ethyl acetate (300 mL) was added and washing was conducted twice. The aqueous layer was acidified with 1 M aqueous hydrochloric acid solution (160 mL), and concentrated in vacuo. Ethanol (300 mL) was added to the residue, and the precipitate was filtered off. The filtrate was concentrated in vacuo. A small amount of diethyl ether was added to the residue, the precipitate was filtered and washed with ethanol and diethyl ether to give the title compound 3a (5.09 g, 49%) as a colorless solid. An analytical sample was prepared by recrystallization from acetone-diethyl ether. 
(4S,5R)-5-Methyl-2-oxooxazolidine-4-carboxylic acid (3b).
To a solution of N-benzyloxycarbonyl-L-threonine (20.0 g, 79 mmol) in methanol (160 mL), 1 M aqueous sodium hydroxide solution (160 mL, 160 mmol) was added and the mixture was stirred for 2 h at room temperature. The mixture was concentrated under reduced pressure. To the residue, ethyl acetate (300 mL) was added and washing was conducted twice. The aqueous layer was acidified with 1 M aqueous hydrochloric acid solution (160 mL) and concentrated in vacuo. Ethanol (300 mL) was added to the residue, and the precipitate was filtered off. The filtrate was concentrated in vacuo. A small amount of diethyl ether was added to the residue, the precipitate was filtered and washed with ethanol and diethyl ether to give the title compound 3b (6.27 g, 55%) as a colorless solid. 
(4S,5S)-5-Methyl-2-oxooxazolidine-4-carboxylic acid (3c).
To a solution of N-benzyloxycarbonyl-allo-L-threonine (4.73 g, 18.0 mmol) in methanol S3 (36.0 mL), 1 M aqueous sodium hydroxide solution (36.0 mL, 36.0 mmol) was added and the mixture was stirred for 4.5 h at room temperature. The mixture was concentrated under reduced pressure. To the residue, ethyl acetate (200 mL) was added and washing was conducted twice. The aqueous layer was acidified with 1 M aqueous hydrochloric acid solution (36.0 mL), and concentrated in vacuo. Ethanol (250 mL) was added to the residue and precipitate was filtered off. The filtrate was concentrated in vacuo. A small amount of diethyl ether was added to the residue, the precipitate was filtered and washed with ethanol and diethyl ether to give the title compound 3c (1.92 g, 73%) as colorless crystals. 
(4S,5R)-5-Methyl-2-oxooxazolidine-4-carboxylic acid benzyl ester (3d).
To an ice cooled solution of (4S,5R)-5-methyl-2-oxooxazolidine-4-carboxylic acid (3b) (2.02 g, 13.9 mmol), benzyl alcohol (2.26 mL, 21.8 mmol) and DMAP (0.068 g, 0.555 mmol) in THF (150 mL), DCC (3.44 g, 16.7 mmol) was added and stirred for 30 min at same temperature. After the ice bath was removed, the reaction mixture was stirred for 5 h. The precipitate was filtered off and the filtrate was concentrated in vacuo. To the mixture, water (30.0 mL) was added and extracted with ethyl acetate (100 mL). The organic layer was washed with 5% aqueous sodium hydrogen carbonate solution (30.0 mL) and water (30.0 mL x 2). The organic layer was dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue was purified by silica gel column chromatography (eluent: toluene-acetone) to afford the title compound 3d (2.98 g, 91%) as a colorless viscous oil. To an ice cooled solution of (4S,5R)-5-methyl-2-oxooxazolidine-4-carboxylic acid benzyl ester (3d) (0.488 g, 2.08 mmol) and iodomethane (0.17 mL, 2.73 mmol) in DMF (6.00 mL), sodium hydride (0.083 g, 2.08 mmol) was added portionwise and stirred for 3 h at same temperature. To the mixture, water (10.0 mL) was added slowly and extracted with ethyl acetate (20.0 mL). The organic layer was washed with water (10.0 mL x 2). The organic layer was dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue was purified by silica gel column chromatography (eluent: toluene-acetone) to afford the title compound 3e (0.444 g, 86%) as a colorless oil. (4S,5R)-3-Benzyl-5-methyl-2-oxooxazolidine-4-carboxylic acid benzyl ester (3f).
To an ice cooled solution of (4S,5R)-5-methyl-2-oxooxazolidine-4-carboxylic acid benzyl ester (3d) (0.706 g, 3.00 mmol) and benzyl bromide (0.39 mL, 3.28 mmol) in DMF (8.00 mL), sodium hydride (0.120 g, 3.00 mmol) was added portionwise and stirred for 3 h at same temperature. To the mixture, water (20.0 mL) was added slowly and extracted with ethyl acetate (40.0 mL). The organic layer was washed with water (20.0 mL x 2). The organic layer was dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue was purified by silica gel column chromatography (eluent: toluene-acetone) to afford the title compound 3f (0.859 g, 88%) as a colorless oil. (4S,5R)-3,5-Dimethyl-2-oxooxazolidine-4-carboxylic acid (3g). To a solution of (4S,5R)-3,5-dimethyl-2-oxooxazolidine-4-carboxylic acid benzyl ester (3e) (0.551 g, 2.21 mmol) in methanol (10.0 mL) and water (1.00 mL), 5% Pd-C (0.150 g) was added and hydrogenated for 1 h at room temperature. The catalyst was filtered through Celite and the filtrate was concentrated in vacuo to give the title compound 3g (0.345 g, 98%) as colorless crystals. (4S,5R)-3-Benzyl-5-methyl-2-oxooxazolidine-4-carboxylic acid (3h). To a solution of (4S,5R)-3-benzyl-5-methyl-2-oxooxazolidine-4-carboxylic acid benzyl ester (3f) (0.850 g, 2.61 mmol) in THF (18.0 mL) and DME (2.70 mL), lithium hydroxide (0.548 g, 13.1 mmol) in water (10.0 mL) was added and stirred for 30 min. To the mixture, water (20.0 mL) was added and extracted with diethyl ether (40.0 mL x 3). To the aqueous layer, 5 M aqueous hydrochloric acid solution (3.00 mL) was added and extracted with ethyl acetate (40.0 mL x 2). The organic layer was dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue was recrystallized from hexane-acetone to give the title compound 3h (0.493 g, 80%) as colorless crystals. 
(4S,5S)-5-Methyl-2-oxooxazolidine-4-carboxylic acid methyl ester (3i).
To an ice cooled solution of (4S,5S)-5-methyl-2-oxooxazolidine-4-carboxylic acid (3c) (1.02 g, 7.00 mmol) in methanol (10.0 mL), thionyl chloride (0.510 mL, 7.00 mmol) was added dropwise and stirred for 10 min under nitrogen atmosphere. The ice bath was removed and stirred continuously for 4 h. The reaction mixture was concentrated in vacuo to afford the title compound 3i (1.11 g, quant) as a colorless solid, which was used without further purification. 
(4R,5S)-5-Methyl-2-oxooxazolidine-4-methanol (3j).
To an ice cooled solution of (4S,5S)-5-methyl-2-oxooxazolidine-4-carboxylic acid methyl ester (3i) (1.11 g, 7.00 mmol) in ethanol (20.0 mL), sodium borohydride (0.265 g, 7.00 mmol) was added portionwise and stirred for 20 min under nitrogen atmosphere. The ice bath was removed and stirred continuously for 1 h. To the mixture, 5 M aqueous hydrochloric acid solution (1.40 mL, 7.00 mmol) was added and stireed for 30 min at room temperature. The mixture was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (eluent: CHCl 3 /MeOH) to afford the title compound 3j (0.702 g, 76%) as colorless crystals. An analytical sample was prepared by recrystallization from acetone/diethyl ether. To a suspension of (4R,5S)-5-methyl-2-oxooxazolidine-4-methanol (3j) (0.262 g, 2.00 mmol) in dichloromethane (13.0 mL) and pyridine (0.33 mL, 4.08 mmol) at -35 °C under nitrogen atmosphere, rifluoromethanesulfonic anhydride (0.40 mL, 2.40 mmol) was added dropwise and stirred for 1.5 h at the same temperature. To the mixture, ehyl acetate (20.0 mL) and water (10.0 mL) were added and extracted. The organic layer was washed with water (10.0 mL). The organic layer was dried over anhydrous magnesium sulfate and concentrated in vacuo to give the title compound 3k (0.235 g, 45%) as purple crystals, which was used without further purification. mp 69-71 °C. (2) Middle-part fragments 4-Chloromethylthiazole (7). To an ice cooled suspension of Lawesson's reagent (400 g, 0.989 mol) in THF (500 mL), S6 formamide (178 g, 3.95 mol) in THF (100 mL) solution was added dropwise for 30 min and the mixture was stirred for 10 min at 0 °C. The ice bath was removed and stirred continuously for 3 h. The mixture was cooled to 0 °C again, 1,3-dichloroacetone (251 g, 1.98 mol) in THF (150 mL) solution was added dropwise for 15 min at the same temperature and the mixture was stirred overnight. The precipitate was filtered and washed with acetone (500 mL x 3) to afford crude 4-chloromethylthiazole hydrochloride. Crude 4-chloromethylthiazole hydrochloride was dissolved in water (500 mL). To this solution, water (300 mL), 5% aqueous sodium hydrogen carbonate solution (500 mL) and toluene (800 mL) were added and extracted. The aqueous layer was extracted with toluene (600 mL x 2). The organic layers were combined and washed with water (1.00 L x 2). The organic layer was dried over anhydrous magnesium sulfate and concentrated in vacuo to afford the title compound 7 (167 g, 63%) as a brown oil. 
Ethyl α-acetamide-α-carboethoxy-β-(thiazol-4-yl)-propionate (8).
Sodium (27.0 g, 1.17 mol) was added portionwise to ethanol (800 mL) and stirred for 1 h at 75 °C. To the mixture, diethyl acetamidemalonate (255 g, 1.18 mol) was added and refluxed for 2 h. To the mixture, potassium iodide (2.70 g, 16.3 mmol) in DMF (2.70 mL) and 4-chloromethylthiazole (7) (157 g, 1.18 mol) in ethanol (100 mL) were added and the mixture was stirred for 3 h at 60 °C. The mixture was cooled to room temperature and concentrated under reduced pressure. To the residue, water (1.00 L) was added and extracted with ethyl acetate (1.00 L x 2). The organic layers were combined and dried over anhydrous magnesium sulfate and concentrated in vacuo to give the title compound 8 (329 g, 89%) as a pale yellow solid. 
3-(Thiazol-4-yl)-DL-alanine dihydrochloride (9).
Ethyl α-acetamide-α-carboethoxy-β-(thiazol-4-yl)-propionate (8) (329 g, 1.05 mol) in 6 M aqueous hydrogen chloride solution (1.75 L, 10.5 mol) was refluxed for 6 h. The mixture was cooled to room temperature and concentrated under reduced pressure until 718 g. The precipitate was filtered and washed with ice cooled ethanol (100 mL x 2) to give the title compound 9 (189 g, 74%) as a colorless solid. 
N-tert-Butoxycarbonyl-3-(thiazol-4-yl)-L-alanine (4a).
To an ice cooled solution of 3-(thiazol-4-yl)-DL-alanine dihydrochloride (9) (150 g, 0.612 mol) in 3 M aqueous sodiun hydroxide solution (600 mL, 2.00 mol), acetic anhydride (63.6 mL, 0.673 mol) was added dropwise and the mixture was stirred for 1 h at the same temperature. The ice bath was removed and the mixture was stirred continuously for 2 h. This solution was adjusted to pH 7.2 with 3 M aqueous sodiun hydroxide solution (50.0 mL, 150 mmol) and acetic anhydride (2.00 mL, 21.2 mmol). To the solution, aminoacylase (17.0 g) was added and stirred for 2 d at 37 °C. The mixture was filtered through Celite, the filtrate was concentrated under reduced pressure. To the residue, triethylamine (42.7 mL, 0.306 mol) and di-tert-butyl dicarbonate (73.5 g, 0.337 mol) were added and the mixture was stirred overnight at room temperature. Ethyl acetate (1.00 L) was added to the mixture and separated. The aqueous layer was adjusted pH 3 with 20% aqueous citric acid solution at 0 °C. This solution was extracted with ethyl acetate (1.00 L x 3). The organic layers were combined and washed with brine (300 mL) and dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue was crystallized from hexane-ethyl acetate to give the title compound 4a (47.4 g, 29%) as colorless crystals. 
2-Trimethylsilylthiazole (12).
1.6 M n-buthyllithium solution in hexane (252 mL, 403 mmol) was added dropwise to diethyl ether (600 mL) at -78 °C under nitrogen atmosphere. To the solution, 2-bromothiazole (60.0 g, 366 mmol) was added dropwise for 15 min and the mixture was stirred for 1 h at the same temperature. Then trimethylsilyl chloride (46.5 mL, 366 mmol) was added dropwise for 1 h and the mixture was stirred for additional 1 h. Saturated aqueous sodium hydrogen carbonate solution (250 mL) was added slowly at 0 °C. The solution was separated and the aqueous layer was extracted with diethyl ether (200 mL). The organic layers were combined and dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue was distilled under reduced pressure to afford the title compound 12 (51.0 g, 89%) as a colorless oil. bp 67-72 °C (28 mmHg). 
5-Formylthiazole (13).
1.6 M n-buthyllithium solution in hexane (11.4 mL, 19.1 mmol) was added dropwise to diethyl ether (40.0 mL) at -78 °C under nitrogen atmosphere. To the solution, 2-trimethylsilylthiazole (12) (3.00 g, 19.1 mmol) in diethyl ether (10.0 mL) solution was added dropwise for 20 min and the mixture was stirred for 1 h at the same temperature. Then N-formylmorpholine (2.10 mL, 2.10 mmol) in diethyl ether (10.0 mL) solution was added dropwise for 15 min and the mixture was stirred for additional 2 h. Saturated aqueous sodium hydrogen carbonate solution (10.0 mL) was added slowly at 0 °C. The solution was separated and the aqueous layer was extracted with diethyl ether (100 mL x 2). The organic layers were combined and dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue was dissolved in THF (30.0 mL), 1 M aqueous hydrochloric acid solution (1.70 mL, 1.70 mmol) was added and stireed for 1 h at room temperature. The mixture was concentrated under reduced pressure. To the mixture, water (30.0 mL) was added and extracted with diethyl ether (100 mL x 2) and ethyl acetate (100 mL x 2). The organic layers were combined and dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue was purified by silica gel column chromatography (eluent: hexane/ethyl acetate) to afford the title compound 13 (1.08 g, 50%) as a pale yellow oil. 
5-Hydroxymethylthiazole (14).
To a suspension of sodium borohydride (0.860 g, 22.8 mmol) in THF (35.0 mL), 5-formylthiazole (13) (2.34 g, 20.7 mmol) in THF (10.0 mL) was added slowly and the mixture was stirred for 2 h at room temperature. The reaction was quenched with aqueous hydrochloric acid solution. To the mixture, saturated aqueous sodium hydrogen carbonate solution was added and extracted with ethyl acetate (100 mL x 10). The organic layers were combined and dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue was purified by silica gel column chromatography (eluent: hexane/ethyl acetate) to afford the title compound 14 (1.45 g, 61%) as a pale yellow oil. An analytical sample was prepared as HCl salt. mp 75-77 °C. 
5-Chloromethylthiazole (15).
To an ice cooled solution of 5-hydroxymethylthiazole (14) (1.52 g, 13.2 mmol), thionyl chloride (2.90 mL, 39.6 mmol) was added dropwise over 5 min and the mixture was stirred for 1 h. The mixture was concentrated and co-evapolated with toluene (10.0 mL x 3). To the residue, saturated aqueous sodium hydrogen carbonate solution (100 mL) was added and extracted with ethyl acetate (100 mL x 2). The organic layers were combined and dried S9 over anhydrous magnesium sulfate and concentrated in vacuo to give the title compound 15 (1.75 g, quant) as a colorless oil. 1 H NMR (200 MHz, DMSO-d 6 ) δ 9.18 (s, 1 H), 7.99 (s, 1 H), 5.14 (s, 2 H).
Ethyl α-acetamide-α-carboethoxy-β-(thiazol-5-yl)-propionate (16).
Sodium ethoxide solution was prepared using sodium (0.760 g, 33.0 mmol) and ethanol (65.0 mL) under nitrogen atmosphere. To the solution, diethyl acetamidemalonate (7.17 g, 33.0 mmol) was added and the mixture was refluxed for 1 h. After cooling to 50 °C, 5-chloromethylthiazole (15) (4.00 g, 30.0 mmol) in ethanol (15.0 mL) was added and the mixture was stirred for 6 h. The precipitate was filtered on Celite and the filtrare was concentrated in vacuo. 
N-Acetyl-3-(thiazol-5-yl)-DL-alanine ethyl ester (17).
To a solution of ethyl α-acetamide-α-carboethoxy-β-(thiazol-5-yl)-propionate (16) (25.0 g, 79.5 mmol) in ethanol (300 mL), 1 M aqueous sodium hydroxide solution (87.5 mL, 87.5 mmol) was added and the mixture was stirred for 2 h at room temperature. 1 M aqueous hydrochloric acid solution (87.5 mL, 87.5 mmol) was added and refluxed for 2 h. After cooling to room temperature, the mixture was concentrated and extracted with ethyl acetate (200 mL x 4). The organic layers were combined and dried over anhydrous magnesium sulfate and concentrated in vacuo to afford the title compound 17 (9.95 g, 52%) as a yellow oil. IR (CHCl 3 ) 
N-tert-Butoxycarbonyl-3-(thiazol-5-yl)-L-alanine (4b).
N-Acetyl-3-(thiazol-5-yl)-DL-alanine ethyl ester (17) (7.30 g, 30.1 mmol) was dissolved in 1 M aqueous sodium hydroxide solution (90.4 mL, 90.4 mmol) and the mixture was stirred for 1 h at room temperature. This solution was adjusted to pH 7.3 with 5 M aqueous hydrochloric acid solution and aminoacylase (0.730 g) was added to this solution. After stirring for 1 d at 37 °C, the mixture was filtered through Celite and the filtrate was concentrated under reduced pressure. The residue was dissolved in 1,4-dioxane (75.0 mL) and water (60.0 mL). To the solution, triethylamine (2.10 mL, 15.1 mmol) and di-tert butyl dicarbonate (3.62 g, 16.6 mmol) were added at 0 °C and the mixture was stirred for 16 h at room temperature. Ethyl acetate (500 mL) was added to the mixture and separated. The aqueous layer was adjusted to pH 3 with 10% aqueous citric acid solution. This solution was extracted with ethyl acetate (500 mL x 3). The organic layers were combined and washed with water (100 mL x 2). The organic layer was dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue was crystallized from hexane-ethyl acetate to give the title compound 4b (3.57 g, 44%) as colorless crystals. ) at -40 °C, triethylamine (43.1 mL, 309 mmol) was added once and ethyl chloroformate (29.5 mL, 309 mmol) was added dropwise for 15 min. The mixture was stirred for 2 h at the same temperature. 28% aqueous ammonia solution (34.1 mL, 562 mmol) was added dropwise for 5 min and the mixture was stirred for additional 2 h. Ethyl acetate (700 mL) and water (100 mL) were added to the mixture and extracted. The organic layer was washed with aqueous sodium hydrogen carbonate solution (100 mL) and brine (100 mL x 2). The organic layer was dried over anhydrous magnesium sulfate and concentrated in vacuo to give the title compound 21 (60.6 g, 87%) as colorless crystals. mp 90-92 °C. 
N-Benzyloxycarbonyl-L-prolylmorpholine (23).
To a solution of N-benzyloxycarbonyl-L-proline (5.00 g, 20.1 mmol), morpholine (1.92 mL, 20.1 mmol) and HOSu (2.31 g, 20.1 mmol) in DMF (100 mL), DCC (4.14 g, 20.1 mmol) was added and stirred for 4 h at room temperature. The precipitate was filtered off and the filtrate was concentrated in vacuo. To the residue, ethyl acetate (100 mL) and 10% aqueous hydrochlolic acid (50.0 mL) were added and extracted. The organic layer was washed with saturated aqueous sodium hydrogen carbonate solution (50.0 mL) and water (100 mL x 2). The organic layer was dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue was crystallized from hexane-ethyl acetate to give the title compound 23 (4.44 g, 70%) as a colorless solid. mp 142-143 °C. 
Methyl (4R)-4-thiazolidinecarboxylate hydrochloride (25).
To an ice cooled solution of (4R)-4-thiazolidinecarboxylic acid (10.0 g, 75.0 mmol) in methanol (100 mL), thionyl chloride (20.0 mL, 274 mmol) was added dropwise for 10 min and the mixture was stirred for 1 h. The mixture was concentreted under reduced pressure. Toluene (10.0 mL) was added to the residue and the precipitate was filtered to give the title compound 25 (13.7 g, 99%) as a colorless solid. mp 160-162 °C. 
N-tert-Butoxycarbonyl-L-prolinamide (27).
To a solution of N-Boc-L-proline (13.0 g, 60.0 mmol) and triethylamine (9.20 mL, 66.0 mmol) in THF (200 mL) at -25 °C, ethyl chloroformate (6.31 mL, 66.0 mmol) was added dropwise for 10 min and the mixture was stirred for continuously for 1.5 h. To the mixture, 28% aqueous ammonia (7.30 mL, 120 mmol) was added and the mixture was stirred for 4 h at -20 °C. Ethyl acetate (300 mL) and water (100 mL) were added to the mixture and extracted. The organic layer was washed with water (100 mL x 2). The organic layer was dried over anhydrous magnesium sulfate and concentrated in vacuo to give the title compound 27 (11.0 g, 86%) as colorless crystals. mp 102-104 °C. 
N-tert-Butoxycarbonyl-(2S)-2-cyanopyrrolidine (28).
To an ice cooled soution of tert-butoxycarbonyl-L-prolinamide (27) (7.94 g, 37.1 mmol) and imidazole (5.04 g, 74.1 mmol) in pyridine (88.0 mL), phosphorous oxychloride (12.8 mL, 148 mmol) was added dropwise for 5 min and the mixture was stirred for 10 min. The ice bath was removed and the mixture was stirred for continuously for 1 h. The mixture was carefully poured into cold saturated aqueous sodium hydrogen carbonate solution (200 mL) and stirred for 30 min. Ethyl acetate (300 mL) was added to the mixture and extracted. The 
(2S)-2-Cyanopyrrolidine p-toluenesulfonate (29).
To an ice cooled solution of N-tert-butoxycarbonyl-(2S)-2-cyanopyrrolidine (28) (2.00 g, 10.2 mmol) in anisole (13.0 mL), trifluoroacetic acid (13.0 mL) was added and the mixture was stirred for 2 h. Ethyl acetate (100 mL) and water (100 mL) were added to the mixture and extracted. p-Toluenesulfonic acid monohydrate (1.94 g, 10.2 mmol) was added to the aqueous layer and the aqueous layer was concentrated in vacuo. The residue was washed with a small amount of diethyl ether to give the title compound 29 (2.84 g, quant) as a white amorphous powder. 
N-tert-Butoxycarbonyl-(2S)-2-pyrrolidinemethanol (30).
To an ice cooled solution of N-tert-butoxycarbonyl-L-proline (172 g, 800 mmol) in THF (1.00 L), 1 M borane-THF complex in THF (1.60 L, 1.60 mol) was added dropwise for 2 h at 4-9 °C and the mixture was stirred continuously for 1 h. The mixture was poured into ice cooled 3 M aqueous hydrochloric acid solution (400 mL). Ethyl acetate (1.50 L) was added and extracted. The organic layer was washed with saturated aqueous sodium hydrogen carbonate solution (400 mL) and water (400 mL x 2). The organic layer was dried over anhydrous magnesium sulfate and concentrated in vacuo to give the title compound 30 (158 g, 98%) as a colorless solid. 
N-tert-Butoxycarbonyl-(2S)-2-[(methylsulfonyl)oxymethyl]pyrrolidine (31).
To an ice cooled solution of N-tert-butoxycarbonyl-(2S)-2-pyrrolidinemethanol (30) (43.4 g, 198 mmol) and triethylamine (31.1 mL, 223 mmol) in THF, methanesulfonyl chloride (16.1 mL, 223 mmol) was added dropwise slowly. The mixture was stirred for 0.5 h at 0 °C and 5 h at room temperature. Ethyl acetate (1.50 L) and water (1.00 L) were added to the mixture and extracted. The organic layer was washed with water (1.00 L x 2). The organic layer was dried over anhydrous magnesium sulfate and concentrated in vacuo to afford the title compound 31 (52.5 g, 95%) as a yellow viscous oil. IR ( 
N-tert-Butoxycarbonyl-(2R)-2-methylpyrrolidine (32). Sodium borohydride (34.2 g, 904 mmol) was added to a solution of N-tert-butoxycarbonyl-(2S)-2-[(methylsulfonyl)oxymethyl]pyrrolidine (31) (127 g, 452
mmol) in dimethylsulfoxide (1.00 L). The mixture was stirred for 7 h at 80 ˚C. The mixture was poured into ice cooled water (1.00 L) and quenched carefully with 10% aqueous hydrochloric acid solution. The mixture was diluted with toluene (2.50 L) and the layers were separated. The organic layer was washed with water (1.00 L x 2) and dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue was distilled under reduced pressure to afford the title compound 32 (37.5 g, 46%) as a colorless oil. Table S1 . To an ice cooled solution of N α -benzyloxycarbonyl-L-histidine hydrazide (3.51 g, 11.6 mmol) in 1 M aqueous hydrochloric acid solution (34.8 mL, 34.8 mmol) and ethyl acetate (46.0 mL), sodium nitrite (0.810 g, 11.7 mmol) in water (2.90 mL) was added and the mixture was stirred for 2 min. 50% aqueous potassium carbonate (13.9 mL) was added and the mixture was stirred for 5 min at 0 °C. The organic layer was separated and dried over anhydrous magnesium sulfate. The magnesium sulfate was filtered off. To the filtrate, L-prolinamide (22) (1.20 g, 10.5 mol) was added and the mixture was stirred for 7 h at 0 °C. The mixture was concentrated in vacuo. The residue was purified by silica gel column chromatography (eluent: CHCl 3 /MeOH/H 2 O) to afford crude product, which was recrystallized from water to give the title compound 36 (1.93 g, 48%) as colorless crystals. N-[N-tert-Butoxycarbonyl-3-(thiazol-4-yl)-L-alanyl]-(2S)-2-cyanopyrrolidine (39) . 
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General Procedure for the Synthesis of N-Protected Dipeptide Mimetics. [N-tert-Butoxycarbonyl-3-(thiazol-4-yl)-L-alanyl]-L-prolinamide (34).
To an ice cooled solution of N-tert-butoxycarbonyl-3-(thiazol-4-yl)-L-alanine
3-N-[N-tert-Butoxycarbonyl-3-(thiazol-4-yl)-L-alanyl]-(4R)-4-thiazolidinecarboxamide (38).
The condensation of N-tert-butoxycarbonyl-3-(thiazol-4-yl)-L-alanine
1-
1-N-[N-tert-Butoxycarbonyl-3-(thiazol-4-yl)-L-alanyl]-(2R)-2-methylpyrrolidine (40). The condensation of N-tert-butoxycarbonyl-3-(thiazol-4-yl)-L-alanine
1-N-(N α -Benzyloxycarbonyl-L-histidyl)-(2R)-2-methylpyrrolidine (42).
To a solution of N α -benzyloxycarbonyl-L-histidine hydrazide (3.00 g, 9.89 mmol) in DMF (25.0 mL) at -78 °C, 4 M hydrogen chloride in 1,4-dioxane solution (7.40 mL, 29.6 mmol) was added dropwise for 20 min. Isoamyl nitrite (1.46 mL, 10.9 mmol) was added and the mixture was stirred for 30 min at the same temperature. Triethylamine (5.50 mL, 39.6 mmol) and (2R)-2-methylpyrrolidine hydrochloride (33) (1.20 g, 9.89 mmol) were added and the mixture was stirred for 5 min. The mixture was warmed to 0 °C and stirred for 2 h. The precipitate was filtered off and the filtrate was concentrated under reduced pressure. Ethyl acetate (100 mL) and saturated aqueous sodium hydrogen carbonate solution (100 mL) were added to the residue and extracted. The organic layer was washed with water (100 mL x 2). The organic layer was dried over anhydrous magnesium sulfate and concentrated in vacuo. The residue was purified by silica gel column chromatography (eluent: CHCl 3 /MeOH) to afford the title compound 42 (0.83 g, 24%) as a white amorphous powder. The yields of dipeptide mimetics 45-55 are shown in Table S2 . Compounds were obtained as HCl salt, HBr salt, TFA salt or free base and were not purified.
General Procedure for the Synthesis of Dipeptide Mimetics. [3-(Thiazol-4-yl)-L-alanyl]-L-prolinamide dihydrochloride (45).
To an ice cooled solution of [N-tert-butoxycarbonyl-3-(thiazol-4-yl)-L-alanyl]-L-prolinamide (34) (5.53 g, 15.0 mmol) in ethyl acetate (30.0 mL), 4 M hydrogen chloride in ethyl acetate solution (75.0 mL, 300 mmol) was added slowly and the mixture was stirred for 2.5 h. Diethyl ether (400 mL) was added to the mixture and the precipitate was filtered off and washed with a small amount of diethyl ether to give 6.67 g of the title compound 45 as a colorless solid, which was used without further purification. Non-hydrogen atoms were shown as thermal ellipsoids at the 50% probability. Three water molecules of Rovatirelin Hydrate were labeled O6, O7 and O8. B eq = 8/3 Π 2 (U 11 (aa*) 2 + U 22 (bb*) 2 + U 33 (cc*) 2 + 2U 12 (aa*bb*)cos γ + 2U 13 (aa*cc*)cos β + 2U 23 (bb*cc*)cos α) The general temperature factor expression: exp(-2Π 2 (a* 2 U 11 h 2 + b* 2 U 22 k 2 + c* 2 U 33 l 2 + 2a*b*U 12 hk + 2a*c*U 13 hl + 2b*c*U 23 kl))
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